Venture Investors
Venture Investors seeks the next big things in healthcare. Based in the Midwest with open access to renowned research universities, and the vibrant communities that surround them, we target, uncover, and invest in extraordinary ideas that will shape the future of health and wellness. With decades of proven success, we’re fueling the future of what’s driving healthcare.
📥 Buy Full VC Dataset
Offices: Madison (United States), Ann Arbor (United States), Milwaukee (United States)
Investment Stages: Pre-Seed, Seed, Series A
Markets: Pharma, Diagnostics, Devices & Digital Health
Founded Year: 1982
Investor Type: Venture Capital
Portfolio Companies: Aerpio Pharmaceuticals, Akebia Therapeutics, BlueWillow Biologics, Cellectar Biosciences, Inc., Delphinus Medical Technologies, Deltanoid Pharmaceuticals, Dvant Pharma, EarliTec Diagnostics, Elephas, Elucent Medical, EnsoData, Euthymics Bioscience, Eximis Surgical, FluGen, Gala, GDXI, HealthMyne, HistoSonics, Intralase, Invenra, Inviragen, Iterion Therapeutics, LenSx, Nerites, NeuMoDx, Neurovance, NeuWave Medical, NimbleGen Systems, Promega, Rivermark Medical, TAI Diagnostics, ThirdWave Molecular Diagnostics, Tissue Regeneration Systems, TomoTherapy, ViaLase, Visana Health, Zystor
Website: https://ventureinvestors.com
Team Page: https://ventureinvestors.com/people/
Portfolio Link: https://ventureinvestors.com/portfolio/
LinkedIn: https://www.linkedin.com/company/venture-investors/
Twitter: https://www.twitter.com/vi_funds
Crunchbase: https://www.crunchbase.com/organization/venture-investors
Comments
No comments yet. Be the first to comment!